We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

208 hedge funds and large institutions have $2.02B invested in Sabra Healthcare REIT in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 102 increasing their positions, 54 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,092% more call options, than puts

Call options by funds: $870K | Put options by funds: $73K

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

89% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 54

61% more capital invested

Capital invested by funds: $1.26B → $2.02B (+$762M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

7% more funds holding

Funds holding: 194208 (+14)

Holders
208
Holders Change
+14
Holders Change %
+7.22%
% of All Funds
6.03%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
29
Increased
102
Reduced
54
Closed
15
Calls
$870K
Puts
$73K
Net Calls
+$797K
Net Calls Change
+$797K
Name Holding Trade Value Shares
Change
Change in
Stake
BA
26
BlackRock Advisors
Delaware
$12.8M +$13M +468,887 +822%
GT
27
Glenmede Trust
Pennsylvania
$11.3M -$7.98M -287,905 -38%
BG
28
BlackRock Group
United Kingdom
$10.8M +$2.55M +91,984 +26%
SAM
29
Securian Asset Management
Minnesota
$10.1M -$2.21M -79,700 -16%
Norges Bank
30
Norges Bank
Norway
$10.1M -$8.08M -291,525 -41%
HRES
31
Heitman Real Estate Securities
Illinois
$9.86M +$475K +17,115 +4%
Neuberger Berman Group
32
Neuberger Berman Group
New York
$9.8M +$11.2M +402,890 New
PCM
33
Palisade Capital Management
New Jersey
$9.78M +$11K +397 +0.1%
NA
34
NS Advisors
Connecticut
$9.51M -$1.21M -43,792 -10%
GXMC
35
Global X Management Company
New York
$9.22M +$527K +19,015 +5%
BIM
36
BlackRock Investment Management
Delaware
$8.74M -$49.3K -1,778 -0.5%
TCM
37
Tekla Capital Management
Massachusetts
$8.35M +$9.52M +343,390 New
Franklin Resources
38
Franklin Resources
California
$8.23M +$13.9K +500 +0.1%
Barclays
39
Barclays
United Kingdom
$8.12M +$8.37M +301,791 +831%
PFMOSF
40
Philadelphia Financial Management of San Francisco
California
$7.9M +$9.01M +325,000 New
AQR Capital Management
41
AQR Capital Management
Connecticut
$7.69M +$1.65M +59,400 +23%
BNP Paribas Asset Management
42
BNP Paribas Asset Management
France
$7.46M +$3.14M +113,178 +58%
PFC
43
Phocas Financial Corp
California
$7.33M +$230K +8,309 +3%
Ameriprise
44
Ameriprise
Minnesota
$7.3M -$8.64M -311,428 -51%
Deutsche Bank
45
Deutsche Bank
Germany
$6.61M +$2.62M +94,387 +53%
HSS
46
Harrison Street Securities
Illinois
$6.4M +$249K +8,989 +4%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$6.36M +$450K +16,221 +7%
FAM
48
Fred Alger Management
New York
$6.1M +$6.96M +250,896 New
GC
49
Guggenheim Capital
Illinois
$5.89M +$3.71M +133,798 +124%
KCM
50
Kennedy Capital Management
Missouri
$5.56M +$1.29M +46,643 +26%

SBRA Hedge Fund Activity: Q3 2014 in Review

208 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q3 2014, worth a combined $2.02B — up 61% from $1.26B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SBRA positions and 15 closed out — a net gain of 14 holders — while 102 added to existing stakes and 54 trimmed.

The largest buyer was Vanguard Group, adding an estimated $22.6M. The largest seller was Bank of New York Mellon, cutting an estimated $29.8M.

  • 208 institutional investors held Sabra Healthcare REIT (SBRA) as of Q3 2014, up from 194 in Q2 2014.
  • Funds reported $2.02B of Sabra Healthcare REIT stock for Q3 2014, up 61% quarter-over-quarter.
  • 29 funds opened new Sabra Healthcare REIT positions in Q3 2014 and 15 closed out, a net change of +14 holders.
  • The largest Sabra Healthcare REIT buyer in Q3 2014 was Vanguard Group, an estimated $22.6M added.
  • The largest Sabra Healthcare REIT seller in Q3 2014 was Bank of New York Mellon, an estimated $29.8M sold.

Based on aggregated 13F filings for Q3 2014.